Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1998 | 1 |
1999 | 1 |
2009 | 1 |
2011 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Tolerance and intolerance to continuous positive airway pressure.
Curr Opin Pulm Med. 1998 Nov;4(6):351-4. doi: 10.1097/00063198-199811000-00008.
Curr Opin Pulm Med. 1998.
PMID: 10813215
Review.
Nasal continuous positive airway pressure (CPAP) is the most effective and widely used therapy for obstructive sleep apnea. As with any chronic therapy, long-term compliance has a significant impact on its effectiveness. Only about half of patients use CPAP for more than h …
Nasal continuous positive airway pressure (CPAP) is the most effective and widely used therapy for obstructive sleep apnea. As with any chro …
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.
Flume PA, Biner RF, Downey DG, Brown C, Jain M, Fischer R, De Boeck K, Sawicki GS, Chang P, Paz-Diaz H, Rubin JL, Yang Y, Hu X, Pasta DJ, Millar SJ, Campbell D, Wang X, Ahluwalia N, Owen CA, Wainwright CE; VX14-661-110 study group.
Flume PA, et al.
Lancet Respir Med. 2021 Jul;9(7):733-746. doi: 10.1016/S2213-2600(20)30510-5. Epub 2021 Feb 10.
Lancet Respir Med. 2021.
PMID: 33581080
Here, we present results of study 661-110 (EXTEND), a 96-week open-label extension study that assessed long-term safety, tolerability, and efficacy of tezacaftor-ivacaftor in participants aged 12 years or older with cystic fibrosis who were homozygous or heterozygous for t …
Here, we present results of study 661-110 (EXTEND), a 96-week open-label extension study that assessed long-term safety, tolerability …
Item in Clipboard
The spectrum of sleep-disordered breathing.
Anstead M, Phillips B.
Anstead M, et al.
Respir Care Clin N Am. 1999 Sep;5(3):363-77, viii.
Respir Care Clin N Am. 1999.
PMID: 10419581
Review.
The term sleep-disordered breathing has been used synonymously with the term obstructive sleep apnea syndrome (OSAS). ...
The term sleep-disordered breathing has been used synonymously with the term obstructive sleep apnea syndrome (OSAS). ...
Item in Clipboard
Lack of association of small-colony-variant Staphylococcus aureus strains with long-term use of azithromycin in patients with cystic fibrosis.
Green N, Burns JL, Mayer-Hamblett N, Kloster M, Lands LC, Anstead M, Ratjen F, Saiman L.
Green N, et al. Among authors: anstead m.
J Clin Microbiol. 2011 Jul;49(7):2772-3. doi: 10.1128/JCM.00835-11. Epub 2011 May 4.
J Clin Microbiol. 2011.
PMID: 21543567
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis.
Schechter MS, McColley SA, Silva S, Haselkorn T, Konstan MW, Wagener JS; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis; North American Scientific Advisory Group for ESCF.
Schechter MS, et al.
J Pediatr. 2009 Nov;155(5):634-9.e1-4. doi: 10.1016/j.jpeds.2009.04.059. Epub 2009 Jul 16.
J Pediatr. 2009.
PMID: 19608199
Free PMC article.
Item in Clipboard
Cite
Cite